Trial Details
Not RecruitingBasic Information
| Clinical ID | c3040 |
|---|---|
| Identifier | JPRN-UMIN000015770 |
| Trial Title | Randomized double-blind multicenter study for anti-inflammatory effects of highly bioavailable curcumin on Crohn's disease. - Exploratory study for effects of highly bioavailable curcumin on Crohn's disease. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | Yes |
|---|---|
| Conditions | Crohn's disease (180 <= CDAI < 450) CDAI: Crohn's disease Activity Index |
| Interventions | Standard therapy for Crohn's disease (Pentasa 3 g/day) Patients take curcumin or placebo |
Participant Information
| Sponsor | Hamamatsu South Hospital, Centre for Gastroenterology and Inflammatory Bowel Disease Research |
|---|---|
| City | - |
| Country/Region | Japan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | INFANT |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | 2017-12-31 |